{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:51Z","timestamp":1786986891489,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,29]],"date-time":"2026-11-29T00:00:00Z","timestamp":1795910400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH121397"],"award-info":[{"award-number":["R01MH121397"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["PR160206"],"award-info":[{"award-number":["PR160206"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinthera.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:52:31Z","timestamp":1759233151000},"page":"1137-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection on Depressive Symptoms in Patients With Posttraumatic Stress Disorder"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-8841","authenticated-orcid":false,"given":"Brian","family":"Shiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley V.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Rozema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimie L.","family":"Gradus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.09.008_bib0001","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3851\/IMP3117","article-title":"Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients","volume":"22","author":"Backus","year":"2017","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.gastro.2016.05.049","article-title":"Effectiveness of Sofosbuvir, Ledipasvir\/Sofosbuvir, or Paritaprevir\/Ritonavir\/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System","volume":"151","author":"Ioannou","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0029-1192055","volume":"29","author":"Burra","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2015.21.2.105","article-title":"Hepatitis C virus-induced hepatocellular carcinoma","volume":"21","author":"Goossens","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0006","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/epirev\/mxu002","article-title":"Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs","volume":"37","author":"Beste","year":"2015","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0007","first-page":"2743","article-title":"Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection","volume":"16","author":"Takeda","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.psy.44.2.104","article-title":"A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C","volume":"44","author":"Dieperink","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0009","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1570159X14666160106155129","article-title":"Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem","volume":"14","author":"Pinto","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement","volume":"57","author":"Schaefer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coph.2016.06.008","article-title":"Psychological side effects of immune therapies: symptoms and pathomechanism","volume":"29","author":"Kovacs","year":"2016","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0012","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0168-8278(05)80402-7","article-title":"Suicide associated with alfa-interferon therapy for chronic viral hepatitis","volume":"21","author":"Janssen","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/1516-4446-2018-0336","article-title":"Incidence of depression in patients with hepatitis C treated with direct-acting antivirals","volume":"42","author":"Egmond","year":"2020","journal-title":"Braz J Psychiatry"},{"issue":"8","key":"10.1016\/j.clinthera.2025.09.008_bib0015","first-page":"1093","article-title":"Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents","volume":"6","author":"Karimi-Sari","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0016","doi-asserted-by":"crossref","first-page":"ofad498","DOI":"10.1093\/ofid\/ofad498","article-title":"Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study","volume":"10","author":"Pericot-Valverde","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4274\/vhd.galenos.2022.2022-4-2","article-title":"Evaluation of Direct-acting Antiviral Agents and Clinical Responses in Chronic Hepatitis C Patients","volume":"28","author":"Zerdal\u0131","year":"2022","journal-title":"Viral Hepatitis Journal"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12888-018-1735-6","article-title":"Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study","volume":"18","author":"Sundberg","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0019","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-230X-13-86","article-title":"Psychiatric treatment considerations with direct acting antivirals in hepatitis C","volume":"13","author":"Sockalingam","year":"2013","journal-title":"BMC Gastroenterol"},{"issue":"24","key":"10.1016\/j.clinthera.2025.09.008_bib0020","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3390\/ijerph16244981","article-title":"An Investigation of the Side Effects, Patient Feedback, and Physiological Changes Associated with Direct-Acting Antiviral Therapy for Hepatitis C","volume":"16","author":"Wu","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/ejhpharm-2019-001889","article-title":"Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus","volume":"28","author":"Margusino-Frami\u00f1\u00e1n","year":"2021","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0022","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1002\/jmv.25772","article-title":"Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice","volume":"92","author":"Margusino-Frami\u00f1\u00e1n","year":"2020","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0023","article-title":"A Real-life Study of the Positive Response to DAA-based Therapies for Hepatitis C in Brazil","author":"Vivaldini","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0024","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12879-020-4922-2","article-title":"Efficacy and tolerability of DAAs in HCV-monoinfected and HCV\/HIV-coinfected patients with psychiatric disorders","volume":"20","author":"de Gennaro","year":"2020","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.psy.49.3.225","article-title":"The effect of pegylated interferon-alpha2b and ribavirin on posttraumatic stress disorder symptoms","volume":"49","author":"Dieperink","year":"2008","journal-title":"Psychosomatics"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0026","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15504263.2022.2123119","article-title":"Changes in Alcohol Consumption following Direct-Acting Antiviral Treatment for Hepatitis C in VA Patients with Comorbid Alcohol Use Disorder and PTSD","volume":"18","author":"Hoyt","year":"2022","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0027","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/aje\/kwac104","article-title":"Comparative Effectiveness of Direct-Acting Antivirals for Posttraumatic Stress Disorder in Veterans Affairs Patients With Hepatitis C Virus Infection","volume":"191","author":"Shiner","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","article-title":"The Veterans Affairs's Corporate Data Warehouse: Uses and Implications for Nursing Research and Practice","volume":"39","author":"Price","year":"2015","journal-title":"Nurs Adm Q"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0029","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/ser0000351","article-title":"Observations from the national implementation of Measurement Based Care in Mental Health in the Department of Veterans Affairs","volume":"17","author":"Resnick","year":"2020","journal-title":"Psychol Serv"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0031","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","article-title":"Monitoring depression treatment outcomes with the patient health questionnaire-9","volume":"42","author":"Lowe","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0032","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.annepidem.2018.08.007","article-title":"Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection","volume":"28","author":"Rentsch","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0033","first-page":"1","article-title":"Association between post-traumatic stress disorder severity and death by suicide in US military veterans: retrospective cohort study","author":"Forehand","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0034","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.genhosppsych.2023.10.012","article-title":"Development and validation of a prognostic index for mental health and substance use disorder burden","volume":"85","author":"Peltzman","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0036","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0038","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21r14079","article-title":"Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis","volume":"83","author":"Braude","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0039","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10597-008-9140-0","article-title":"Hepatitis C services and individuals with serious mental illness","volume":"44","author":"Goldberg","year":"2008","journal-title":"Community Ment Health J"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0040","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2021.10.008","article-title":"Mining Clinical Data for Novel Posttraumatic Stress Disorder Medications","volume":"91","author":"Shiner","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0041","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.genhosppsych.2023.06.012","article-title":"Safety of Glecaprevir\/Pibrentasvir for hepatitis C in patients with posttraumatic stress disorder: A post-marketing surveillance study","volume":"84","author":"Shiner","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0042","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/NMD.0000000000000322","article-title":"A Meta-Analysis of Depressive Symptom Outcomes in Randomized, Controlled Trials for PTSD","volume":"203","author":"Ronconi","year":"2015","journal-title":"J Nerv Ment Dis"},{"issue":"6","key":"10.1016\/j.clinthera.2025.09.008_bib0043","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13244","article-title":"Comparing Medications for DSM-5 PTSD in Routine VA Practice","volume":"81","author":"Shiner","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0044","article-title":"Open Label Study of Glecaprevir\/Pibrentasvir for the Treatment of PTSD","author":"Watts","year":"2024","journal-title":"ClinicalTrials.gov"},{"key":"10.1016\/j.clinthera.2025.09.008_bib0045","article-title":"Randomized Placebo-Controlled Trial of Glecaprevir\/\u200bPibrentasvir for Post-traumatic Stress Disorder","author":"Watts","year":"2024","journal-title":"ClinicalTrials.gov"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825003170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T09:09:37Z","timestamp":1764407377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825003170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0149291825003170"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.09.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection on Depressive Symptoms in Patients With Posttraumatic Stress Disorder","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}